Chat with Enda
πŸ“ž +27 74 337 2721  |  βœ‰οΈ endamari100@gmail.com πŸ‡ΏπŸ‡¦ South Africa  β€’  glp1peptides.co.za
πŸ“± Enquire on WhatsApp

HD MOTS-C 10MG VIAL

R 900

 

MOTS-C 10mg – HD Laboratories

MOTS-C is a mitochondrial-derived peptide (MDP) researched for its role in cellular energy regulation and metabolic signaling. Naturally encoded within mitochondrial DNA, MOTS-C functions as a metabolic messenger that helps regulate stress adaptation, glucose utilization, and mitochondrial efficiency.

 

The 10mg vial by HD Laboratories contains high-purity lyophilized MOTS-C intended for laboratory and research applications.

 

Mechanism of Action

MOTS-C is classified as a mitochondrial β€œmitokine” and primarily exerts its effects through metabolic signaling pathways:

AMPK Activation – Stimulates AMP-activated protein kinase, a key cellular energy sensor.

Enhanced Glucose Uptake – May promote improved glucose utilization at the cellular level.

Fatty Acid Oxidation Support – Encourages metabolic flexibility.

Nuclear Gene Regulation – Influences transcription factors associated with stress adaptation and metabolic balance.

Mitochondrial Efficiency – Supports cellular resilience under metabolic stress conditions.

Its mechanism makes it a peptide of interest in research related to metabolic health, body composition, endurance performance, and longevity pathways.

 

Potential Research Applications

While human clinical data remains limited, MOTS-C is commonly explored in research contexts for:

Metabolic optimization

Insulin sensitivity support

Body composition improvement

Exercise endurance and recovery

Healthy aging and mitochondrial support

All applications remain investigational.

 

Recommended Research Dosing Protocols

⚠ There are no FDA-approved or clinically established human dosing guidelines for MOTS-C. The following reflects commonly observed research practices and community protocols.

 

General Administration

Route: Subcutaneous (SC) injection

Typical Dose Range: 5–10mg per administration

Frequency: 2–3 times per week

Cycle Duration: 4–12 weeks

Break Period: 4–8 weeks off between cycles

 

Storage: Refrigerate at 2–8Β°C after reconstitution

 

Goal-Specific Protocol Examples

1. Metabolic Optimization

Dose: 5–10mg

Frequency: 2–3Γ— weekly

Timing: Morning or before meals

Cycle: 8–12 weeks

Intended to align with circadian metabolic signaling and glucose regulation pathways.

2. Body Composition & Fat Oxidation

Dose: ~10mg per week (split into 2–3 injections)

Timing: 30–60 minutes before exercise

Cycle: 8–12 weeks

Often paired with structured nutrition and resistance training protocols.

3. Endurance & Athletic Performance

Dose: 10mg weekly (divided doses)

Timing: 30–60 minutes pre-workout

Cycle: 6–8 weeks

Explored for its interaction with exercise-induced AMPK activation.

4. Longevity & Mitochondrial Research

Dose: 5–10mg weekly

Frequency: 2Γ— weekly

Cycle: 10–12+ weeks

Focuses on mitochondrial stress resilience and metabolic health pathways.

 

Timing Considerations

Morning administration may align with fasting metabolic activity.

Pre-workout dosing is often utilized to synergize with exercise-induced metabolic activation.

Consistency in weekly timing appears more important than exact hour of administration.

 

Administration Guidelines

Reconstitute with bacteriostatic water using sterile technique.

Inject subcutaneously using an insulin syringe.

Rotate injection sites (abdomen, thigh, upper arm).

Do not shake vigorously during reconstitution.

Discard if solution becomes cloudy or discolored.